Join to View Full Profile
925 Gessner550Houston, TX 77024
Phone+1 713-467-1722
Fax+1 713-467-1704
Dr. Doshi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Henry Ford Health/Henry Ford HospitalFellowship, Hematology and Medical Oncology, 2005 - 2008- Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 2002 - 2005
J.J.M. Medical CollegeClass of 2000
Certifications & Licensure
TX State Medical License 2008 - 2026
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Nivolumab Plus Ipilimumab in the United States.Gurjyot K Doshi, Andrew J Osterland, Ping Shi, Annette Yim, Viviana Del Tejo
JCO Clinical Cancer Informatics. 2024-12-01 - 54 citationsOverall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.Toni K Choueiri, Piotr Tomczak, Se Hoon Park, Balaji Venugopal, Tom Ferguson
The New England Journal of Medicine. 2024-04-18 - 359 citationsAdjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.Toni K Choueiri, Piotr Tomczak, Se Hoon Park, Balaji Venugopal, Thomas Ferguson
The New England Journal of Medicine. 2021-08-19
Press Mentions
Drugmakers Limit Cancer Patient Access to Financial LifelineJanuary 16th, 2025- Cancer Deaths on Decline While Patient Quality of Life ImprovesFebruary 13th, 2020
- Report: Largest One-Year Drop in Cancer-Related Deaths EverJanuary 30th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
